BioAlliance Pharma Provides An Update On Its Partnerships For Loramyc®/Oravig®
4/1/2014 1:58:25 PM
BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, updates on Loramyc®/Oravig® development programs by its Asian partners and on its US partnership.
Help employers find you! Check out all the jobs and post your resume.
comments powered by